Yuan-Chin Tsai

https://orcid.org/0000-0003-3264-3513

Emailyuanchin@tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2008 Ph.D Rutgers UniversityPharmacology
1998 M.S., Institute of Biochemistry and Molecular Biology
1996 B.S., Department of Agriculture Chemistry, National Taiwan University

Experience

2018- Assiociate Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2018- Assiociate Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
2013-2018 Assistant Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
2009-2013 Postdoc, Princeton University

Research Interests

DNA damage
tumor biology
vaccine design

URL

http://depsys.tmu.edu.tw/tchinfo_public/tchinfo.aspx?f=my2&key=&key1=yuanchin

Fingerprint

Dive into the research topics where Yuan-Chin Tsai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

6 Finished

Studies of Prostate Cancer Progression after Androgen-Deprivation Therapy and Development of Cancer Immunotherapy via Anti-Inflammation Approaches
Tsai, Y.
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
Roles of Microrna96 in Tgfβ-Mediated Tumor Progression
Tsai, Y.
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
Roles of microRNA96 in TGF-beta-Mediated Tumor Progression(2/3)
Tsai, Y.
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Roles of microRNA96 in TGF-beta-Mediated Tumor Progression
Tsai, Y.
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
TMU102-AE1-B30
Tsai, Y.
4/1/14 → 12/31/16
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty

1207 Citations
16 h-Index
31 Article
1 Editorial

Roles of interleukin-1 receptor antagonist in prostate cancer progression
Fan, Y. C., Lee, K. D. & Tsai, Y. C., Dec 2020, In: Biomedicines. 8, 12, p. 1-13 13 p., 602.
Research output: Contribution to journal › Article › peer-review

Open Access
Tumor-infiltrating leukocytes suppress local inflammation via interleukin-1 receptor antagonist in a syngeneic prostate cancer model
Fan, Y. C., Chen, W. Y., Lee, K. D. & Tsai, Y. C., Apr 2020, In: Biology. 9, 4, 67.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Tsai, Y. C., Chen, W. Y., Abou-Kheir, W., Zeng, T., Yin, J. J., Bahmad, H., Lee, Y. C. & Liu, Y. N., May 1 2018, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1864, 5, p. 1717-1727 11 p.
Research output: Contribution to journal › Article › peer-review
16 Citations (Scopus)
A synergistic anti-cancer effect of troglitazone and lovastatin in a human anaplastic thyroid cancer cell line and in a mouse xenograft model
Zhong, W. B., Tsai, Y. C., Chin, L. H., Tseng, J. H., Tang, L. W., Horng, S., Fan, Y. C. & Hsu, S. P., Jul 1 2018, In: International Journal of Molecular Sciences. 19, 7, 1834.
Research output: Contribution to journal › Article › peer-review
8 Citations (Scopus)
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. C., Zeng, T., Abou-Kheir, W., Yeh, H. L., Yin, J. J., Lee, Y. C., Chen, W. Y. & Liu, Y. N., Feb 19 2018, In: Molecular Cancer. 17, 1, 42.
Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)